Department of Nursing, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center, Shanghai, China.
Department of Psychogeriatrics, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center, Shanghai, China.
J Clin Nurs. 2020 Sep;29(17-18):3414-3424. doi: 10.1111/jocn.15379. Epub 2020 Jul 2.
To develop a Chinese version of Auditory Hallucination Risk Assessment Scale and evaluate its psychometric properties.
Auditory hallucination, a common symptom in schizophrenia, has the potential to cause harm to patients and the people around them. However, there has been a paucity of suitable instrument developed in Asian region that can comprehensively and reliably assess its risk and inform interventions.
This study involved 2 stages, the development of the Auditory Hallucination Risk Assessment Scale (AHRAS) and testing the psychometric properties of AHRAS. We followed STROBE guidelines in reporting the study.
Auditory Hallucination Risk Assessment Scale items were developed based on Symptom Management Theory, systematic literature review and findings of a qualitative study on the experience of auditory hallucinations. The items were evaluated by content validity. Auditory Hallucination Risk Assessment Scale was then tested for construct validity, concurrent validity, predictive validity, internal consistency and test-retest reliability in a convenience sample of 156 patients with a diagnosis of schizophrenia.
The final version of AHRAS has nine items. Two factors were extracted from AHRAS, which explained 57.74% of the total variance. The score of AHRAS was strongly correlated with that of the Psychotic Symptom Rating Scales-Auditory Hallucinations. The area under the curve was 0.90 for the overall AHRAS score. Sensitivity (86.5%) and specificity (80.0%) were maximal for a mean overall AHRAS score of 13.5, suggesting that this is an appropriate threshold for differentiation. Cronbach's alpha coefficient for internal consistency was 0.82, and intra-class correlation coefficient for test-retest reliability was 0.84.
Auditory Hallucination Risk Assessment Scale has good reliability and validity. It can be used in clinical settings in China and beyond to assess the risk of auditory hallucinations.
Auditory Hallucination Risk Assessment Scale can serve as a tool for nurses and other healthcare professionals to identify patients with high-risk auditory hallucinations, monitor the changes of risk and inform nursing interventions.
开发中文版听觉幻觉风险评估量表，并评估其心理测量特性。
听觉幻觉是精神分裂症的常见症状，有可能对患者及其周围的人造成伤害。然而，亚洲地区缺乏能够全面、可靠地评估其风险并为干预措施提供信息的合适工具。
本研究分为两个阶段，即听觉幻觉风险评估量表（AHRAS）的开发和 AHRAS 心理测量特性的测试。我们遵循 STROBE 指南报告研究。
听觉幻觉风险评估量表的项目是根据症状管理理论、系统文献回顾和听觉幻觉体验的定性研究结果开发的。项目经过内容有效性评估。然后，在 156 名精神分裂症患者的方便样本中，对听觉幻觉风险评估量表进行了结构效度、同时效度、预测效度、内部一致性和重测信度的测试。
AHRAS 的最终版本有 9 个项目。AHRAS 提取了两个因子，解释了总方差的 57.74%。AHRAS 的得分与精神病症状评定量表-听觉幻觉的得分高度相关。AHRAS 总分的曲线下面积为 0.90。对于平均总分 13.5 的 AHRAS，灵敏度（86.5%）和特异性（80.0%）最高，表明这是一个适当的区分阈值。内部一致性的克朗巴赫 α系数为 0.82，重测信度的组内相关系数为 0.84。
听觉幻觉风险评估量表具有良好的信度和效度。它可在中国及其他地区的临床环境中用于评估听觉幻觉的风险。
听觉幻觉风险评估量表可作为护士和其他医护人员识别高风险听觉幻觉患者的工具，监测风险变化并为护理干预提供信息。
Zotero 插件